Description
fMLFK is a peptide that binds n-formyl peptide receptors (FPRs) on neutrophils, playing a role in neutrophil activation.
| Product Unit Size | Cost | Quantity | Stock |
|---|
fMLFK is a peptide that binds n-formyl peptide receptors (FPRs) on neutrophils, playing a role in neutrophil activation.
| Cas No. | 104180-18-9 |
|---|---|
| Purity | ≥95% |
| Formula | C27H43N3O5S |
| Formula Wt. | 565.74 |
| Synonym | Chemotactic peptide, N-Formyl-Met-Leu-Phe-Lys |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
He HQ, Troksa EL, Caltabiano G, et al. Structural determinants for the interaction of formyl Peptide receptor 2 with Peptide ligands. J Biol Chem. 2014 Jan 24;289(4):2295-306. PMID: 24285541.
Peptide used to measure in vitro calcineurin ac...
Histamine H1 antagonist.
Aldehyde dehydrogenase, 26S proteasome, MGMT in...
Statin; HMG-CoA reductase inhibitor.
Glucocorticoid
NS3/4A serine protease inhibitor.
Synthesis impurity
ITC precursor found in cruciferous vegetables.<...
SIRT inhibitor.
Sesquiterpene lactone found in Ginkgo; GABA-A a...
Centrally acting muscle relaxant.
FAK inhibitor.
Synthetic steroid hormone, estrogen analog, use...
GABA-A agonist, NMDA antagonist, voltage-gated ...
PDE and adenosine deaminase inhibitor.
Toxin found in Aconitum; voltage-gated Na+ chan...
Tyrphostin; VEGFR inhibitor.
Endogenous sphingosine-based lipid, component o...
Imidazoline and α2-adrenergic agonist, Nav1.7 ...
Arylbenzimidazole; CHK2 inhibitor.